X
Wedesday, May 14, 2025
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Facilities & Operation

G-CON Manufacturing Selected to Build Aseptic Formulation and Filling PODs for UTHSC

Yuvraj_pawp by Yuvraj_pawp
31st March 2015
in Facilities & Operation

G-CON Manufacturing has been selected to build a multi-POD ISO Class 7 Formulation and Filling Suite for the University of Tennessee Health Science Center (UTHSC).

The new facility in Memphis, Tennessee, will expand the capabilities of the UTHSC Plough Center for sterile drug delivery, which is currently used for process development, analytical and stability studies.

In addition, it will be used for hands-on training in aseptic processing and sterilisation techniques.

UTHSC executive vice-chancellor Dr Kennard Brown said: “The Plough Center hopes to become recognised for its ability to formulate and manufacture difficult to produce new drug products for clinical trials, and for paving the way for manufacturing medicines of the future such as antibody-drug conjugates, nanoparticles and bio-similars.”

The PODs will provide approximately 1,800ft² of cleanroom space and incorporate areas for component preparation, compounding/formulation, filling and lyophilisation for use in manufacturing clinical and small-scale products.

An additional POD will provide approximately 760ft² of cleanroom space for the manufacturing and development of semi-solids products.

G-CON director of Sales Engineering Dennis Powers said: “UTHSC’s selection is a reflection of the market’s increased interest in combining aseptic filling processes within our cleanroom POD technology.

“Integrated designs like these can be replicated or redeployed anywhere in the world as needed.”

G-CON was selected as part of a project team that includes brg3s Architects, ETFC Architects, DPS Consulting and DPS Engineering.

DPS Consulting will provide pharmaceutical consulting and guidance, while DPS Engineering will provide process architecture and design for the PODs.

Previous Post

GSK to provide meningitis B vaccine in UK

Next Post

Novartis's Jadenu receives FDA approval to treat chronic iron overload

Related Posts

Facilities & Operation

Robust Supply Chains Are Essential For Affordable Drugs

18th May 2024
Essential Elements of Quality Management In Lab Practices
Facilities & Operation

8 Essential Elements of Quality Management In Lab Practices

18th May 2024
Facilities & Operation

FDA Solidifies Its Authority Over Laboratory-Developed Tests

18th May 2024
Facilities & Operation

100% Renewable Electricity Record Hit By Charles River Labs

17th May 2024
Facilities & Operation

All Infinity Laboratories Locations Are Now ISO-Accredited

17th May 2024
FDA Solidifies Its Authority Over Laboratory-Developed Tests
Facilities & Operation

Apt Teamwork Holds Key To Successful Lab Design Projects

15th May 2024
Next Post

Perrigo completes acquisition of OTC drugmaker Omega Pharma for $4.5bn

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Notifications